Ataraxis AI (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotech and Health
- Funding URL
- View Funding Page
- Funding Amount:
- $20,400,000
Company Info
- Traction
- Ataraxis plans to launch its first commercial test for breast cancer to U.S. oncologists and aims to impact at least half of new cancer cases by 2030.
- Founders
- Jan Witowski, Krzysztof Geras
- Company Description
- Ataraxis AI is focused on using AI to accurately predict cancer outcomes and personalize treatment, potentially avoiding unnecessary chemotherapy for patients.
- Market
- Cancer treatment
- Location
- New York, USA
- Coinvestors
- AIX Ventures, Thiel Bio, Founders Fund, Floating Point, Bertelsmann, Giant Ventures, Obvious Ventures